Advances in systemic therapy for metastatic breast cancer: future perspectives
2017 · Medical Oncology · 43 citations
https://doi.org/10.1007/s12032-017-0975-5
N
Navid Sobhani
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
92
Papers
2.1K
Citations
23
h-index
45
i10-index
Navid Sobhani is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Advanced Breast Cancer Therapies & Immunotherapy and Immune Responses. The author has an h-index of 23, co-authored 79 publications.
ORCID: 0000-0003-1381-0283Papers by this author
worksAdvances in anti-BRAF therapies for lung cancer
2021 · Investigational New Drugs · 39 citations
https://doi.org/10.1007/s10637-021-01068-8
HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8+T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma
2023 · iScience · 19 citations
https://doi.org/10.1016/j.isci.2023.106143
Comparison of DNA vaccines with AddaS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2
2024 · iScience · 3 citations
https://doi.org/10.1016/j.isci.2024.110969
Investigation of mesenchymal stem cell secretome on breast cancer gene expression: A bioinformatic approach to identify differentially expressed genes, functional networks, and potential therapeutic targets
2024 · Computational Biology and Chemistry · 1 citations
https://doi.org/10.1016/j.compbiolchem.2024.108331
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat